PreveCeutical Medical Stock Forecast, Price & News

+0.00 (+6.67 %)
(As of 09/17/2021 03:42 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume30,000 shs
Average Volume286,276 shs
Market Capitalization$9.82 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PRVCF News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

PreveCeutical Medical logo

About PreveCeutical Medical

PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

PreveCeutical Medical (OTCMKTS:PRVCF) Frequently Asked Questions

What stocks does MarketBeat like better than PreveCeutical Medical?

Wall Street analysts have given PreveCeutical Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PreveCeutical Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting PreveCeutical Medical?

PreveCeutical Medical saw a decrease in short interest in August. As of August 31st, there was short interest totaling 3,800 shares, a decrease of 89.6% from the August 15th total of 36,700 shares. Based on an average daily trading volume, of 144,800 shares, the short-interest ratio is currently 0.0 days.
View PreveCeutical Medical's Short Interest

When is PreveCeutical Medical's next earnings date?

PreveCeutical Medical is scheduled to release its next quarterly earnings announcement on Friday, September 24th 2021.
View our earnings forecast for PreveCeutical Medical

How has PreveCeutical Medical's stock price been impacted by Coronavirus (COVID-19)?

PreveCeutical Medical's stock was trading at $0.0149 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PRVCF stock has increased by 28.9% and is now trading at $0.0192.
View which stocks have been most impacted by COVID-19

Who are PreveCeutical Medical's key executives?

PreveCeutical Medical's management team includes the following people:
  • Stephen Van Deventer, Chairman & Chief Executive Officer
  • Makarand Jawadekar, President, Director & Chief Science Officer
  • Shabira Rajan, Chief Financial Officer & Controller
  • Harry Parekh, Chief Research Officer
  • Alicia Rebman, Marketing Director

Who are some of PreveCeutical Medical's key competitors?

What is PreveCeutical Medical's stock symbol?

PreveCeutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF."

How do I buy shares of PreveCeutical Medical?

Shares of PRVCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PreveCeutical Medical's stock price today?

One share of PRVCF stock can currently be purchased for approximately $0.02.

How much money does PreveCeutical Medical make?

PreveCeutical Medical has a market capitalization of $9.82 million.

What is PreveCeutical Medical's official website?

The official website for PreveCeutical Medical is www.preveceutical.com.

Where are PreveCeutical Medical's headquarters?

PreveCeutical Medical is headquartered at 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3.

How can I contact PreveCeutical Medical?

PreveCeutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3. The company can be reached via phone at (604) 416-7777 or via email at [email protected].

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.